Caribou Biosciences (CRBU) Other Non Operating Income (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Other Non Operating Income data on file, last reported at $1.2 million in Q1 2026.

• Other Non Operating Income for Q1 2026 came in at $1.2 million, down 59.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.4 million (down 53.42% YoY), and the FY2025 annual result was $8.8 million, down 49.57% from the prior year.
• Other Non Operating Income eased to $1.2 million in Q1 2026 per CRBU's latest filing, from $2.2 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $5.3 million in Q4 2024 and troughed at $257000.0 in Q1 2022.
• A 5-year average of $2.8 million and a median of $2.8 million in 2023 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2022 and 2026: Other Non Operating Income soared 1506.25% in 2022, then slumped 59.1% in 2026.
• A 5-year view of Other Non Operating Income shows it stood at $2.3 million in 2022, then jumped by 106.61% to $4.8 million in 2023, then rose by 10.26% to $5.3 million in 2024, then slumped by 58.57% to $2.2 million in 2025, then plunged by 45.68% to $1.2 million in 2026.
• Business Quant data shows CRBU's Other Non Operating Income at $1.2 million in Q1 2026, $2.2 million in Q4 2025, and $1.9 million in Q3 2025.